Optimising Health through Physiological Hormone Replacement


Diurnal has major competencies in the development of innovative medicines for the treatment of endocrine (hormone) disorders, and is focused on building a strong product portfolio within this field. Diurnal innovative development activities in circadian-based endocrinology have yielded novel product opportunities relating to:

  • Steroid Hormone
  • Testosterone
  • Thyroid Hormone

Diurnal wishes to enter into development and commercialization partnerships in these and other areas to create a broad pipeline of therapeutics for endocrine diseases. Diurnal will out-license marketing rights to successful development projects once clinical proof-of-principle has been achieved.

If you wish to contact our Business Development team please click here

Coming Soon


Phase 1 completed December 2009. Moving into Phase 2 mid-June 2010